Companion Animal Growth Vetoquinol reports companion animal products accounting for 72.6% of total sales in H1 2026, signaling strong demand in pet care. This presents a sales opportunity to expand product uptake with clinics and distributors focusing on companion animal portfolios and preventative care programs.

Global Expansion Operating in 24 countries with distributor networks reaching over 80 countries indicates a broad international reach. Sales teams can target regional partners for expanded distribution, co-marketing initiatives, and new market entry strategies in underpenetrated regions.

Digital Ecosystem Adoption of tools like VetImpress, Command Centre ACT, and multiple marketing platforms suggests a data-driven approach to veterinary practice management and revenue optimization. There is an opportunity to upsell analytics, dashboards, and integrated training services to optimize vaccine scheduling and farm visits.

Sustainability & Partnerships Active partnerships in social impact and One Health initiatives point to a values-aligned growth path. Leverage these programs to co-create value propositions with distributors and clinics around responsible sourcing, pet health education, and community outreach, expanding customer loyalty.

Financial Health & Scale Strong mid-year performance with rising net income and substantial revenue in the multi-hundred-million range signals capacity for larger deal sizes, longer-term contracts, and investment in joint development projects with key partners and tier-one distributors.